Literature DB >> 30132279

Targeting myeloid cells in ischemic retinal vascular diseases.

Christina Nürnberg1,2, Norbert Kociok3, Antonia M Joussen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30132279     DOI： 10.1007/s00417-018-4107-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  19 in total

1.  Potential role of microglia in retinal blood vessel formation.

Authors:  Daniella Checchin; Florian Sennlaub; Etienne Levavasseur; Martin Leduc; Sylvain Chemtob
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

Review 2.  Microglia in the healthy and degenerating retina: insights from novel mouse models.

Authors:  Marcus Karlstetter; Stefanie Ebert; Thomas Langmann
Journal:  Immunobiology       Date:  2010-06-04       Impact factor: 3.144

3.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

4.  Vitreal macrophages express vascular endothelial growth factor in oxygen-induced retinopathy.

Authors:  H L Naug; J Browning; G A Gole; G Gobé
Journal:  Clin Exp Ophthalmol       Date:  2000-02       Impact factor: 4.207

5.  Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.

Authors:  Juanjuan Wang; Xueliang Xu; Michael H Elliott; Meili Zhu; Yun-Zheng Le
Journal:  Diabetes       Date:  2010-06-08       Impact factor: 9.461

6.  Macrophage depletion inhibits experimental choroidal neovascularization.

Authors:  Eiji Sakurai; Akshay Anand; Balamurali K Ambati; Nico van Rooijen; Jayakrishna Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-08       Impact factor: 4.799

7.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

8.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Authors:  E A Pierce; R L Avery; E D Foley; L P Aiello; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

9.  M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Authors:  Yoshiaki Kubota; Keiyo Takubo; Takatsune Shimizu; Hiroaki Ohno; Kazuo Kishi; Masabumi Shibuya; Hideyuki Saya; Toshio Suda
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307

10.  Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.

Authors:  Sidath E Liyanage; Alessandro Fantin; Pilar Villacampa; Clemens A Lange; Laura Denti; Enrico Cristante; Alexander J Smith; Robin R Ali; Ulrich F Luhmann; James W Bainbridge; Christiana Ruhrberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-24       Impact factor: 8.311
View more
  1 in total

1.  Progranulin deficiency in Iba-1+ myeloid cells exacerbates choroidal neovascularization by perturbation of lysosomal function and abnormal inflammation.

Authors:  Kei Takahashi; Shinsuke Nakamura; Wataru Otsu; Masamitsu Shimazawa; Hideaki Hara
Journal:  J Neuroinflammation       Date:  2021-07-25       Impact factor: 8.322
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.